142 related articles for article (PubMed ID: 26839961)
21. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
[TBL] [Abstract][Full Text] [Related]
22. Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR‑126 in esophageal squamous cell carcinoma.
Li H; Meng F; Ma J; Yu Y; Hua X; Qin J; Li Y
Oncol Rep; 2014 Sep; 32(3):1225-33. PubMed ID: 25017784
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
24. Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma.
Zhao SL; Zhu ST; Hao X; Li P; Zhang ST
Dis Esophagus; 2011 Nov; 24(8):601-10. PubMed ID: 21539677
[TBL] [Abstract][Full Text] [Related]
25. The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor.
Wang H; Wang Y; Liang B; He F; Li Y; Che J; Li X; Zhao H; Shi G
J Cancer Res Ther; 2016 Oct; 12(Supplement):60-63. PubMed ID: 27721256
[TBL] [Abstract][Full Text] [Related]
26. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
27. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
28. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma.
Moghbeli M; Abbaszadegan MR; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Forghanifard MM
Med Oncol; 2013 Jun; 30(2):516. PubMed ID: 23456637
[TBL] [Abstract][Full Text] [Related]
29. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
30. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
[TBL] [Abstract][Full Text] [Related]
31. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
[TBL] [Abstract][Full Text] [Related]
32. Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer.
Huang J; Liang ZD; Wu TT; Hoque A; Chen H; Jiang Y; Zhang H; Xu XC
Cancer Res; 2007 Feb; 67(4):1589-93. PubMed ID: 17308098
[TBL] [Abstract][Full Text] [Related]
33. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma.
Leung AC; Wong VC; Yang LC; Chan PL; Daigo Y; Nakamura Y; Qi RZ; Miller LD; Liu ET; Wang LD; Li JL; Law S; Tsao SW; Lung ML
Int J Cancer; 2008 Feb; 122(3):587-94. PubMed ID: 17943723
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.
Mizuiri H; Yoshida K; Toge T; Oue N; Aung PP; Noguchi T; Yasui W
Cancer Sci; 2005 Sep; 96(9):571-7. PubMed ID: 16128742
[TBL] [Abstract][Full Text] [Related]
35. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.
Jiao X; Liu R; Huang J; Lu L; Li Z; Xu L; Li E
Curr Protein Pept Sci; 2020; 21(5):507-516. PubMed ID: 32013828
[TBL] [Abstract][Full Text] [Related]
36. The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.
Zhang C; Xiang T; Li S; Ye L; Feng Y; Pei L; Li L; Wang X; Sun R; Ren G; Tao Q
Cell Death Dis; 2018 May; 9(5):573. PubMed ID: 29760376
[TBL] [Abstract][Full Text] [Related]
37. DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
Ng HY; Ko JM; Yu VZ; Ip JC; Dai W; Cal S; Lung ML
Int J Cancer; 2016 Jun; 138(12):2940-51. PubMed ID: 26856390
[TBL] [Abstract][Full Text] [Related]
38. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms.
Vreeland AC; Levi L; Zhang W; Berry DC; Noy N
J Biol Chem; 2014 Dec; 289(49):34065-73. PubMed ID: 25320093
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis.
Yuen HF; Chan YP; Wong ML; Kwok WK; Chan KK; Lee PY; Srivastava G; Law SY; Wong YC; Wang X; Chan KW
J Clin Pathol; 2007 May; 60(5):510-4. PubMed ID: 16822877
[TBL] [Abstract][Full Text] [Related]
40. Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma.
Moghbeli M; Rad A; Farshchian M; Taghehchian N; Gholamin M; Abbaszadegan MR
J Gastrointest Cancer; 2016 Sep; 47(3):273-7. PubMed ID: 27142513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
